🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

BofA raises Addus HomeCare shares target on strong earnings

EditorEmilio Ghigini
Published 07/05/2024, 11:06
ADUS
-

On Tuesday, BofA Securities adjusted its outlook for Addus HomeCare Corporation shares, increasing the firm's price target on the stock to $118 from the previous $115. The investment firm has maintained a Buy rating for the NASDAQ-listed company, citing better-than-expected earnings and a strong growth profile.

Addus HomeCare reported adjusted EBITDA that was $3 million or 11% above the consensus and 5% above BofA Securities' estimate, primarily due to significantly improved margins. Revenues met expectations, while adjusted earnings per share were 10% higher than the consensus.

The positive financial results were attributed to stronger revenues in Personal Care and hospice services, which helped to balance out weaker performance in home health relative to consensus expectations.

In response to the earnings beat, BofA Securities has raised its EBITDA estimates for Addus HomeCare. The new price objective of $118 reflects a valuation of 14.4 times the projected 2024 EBITDA, a slight decrease from the previous multiple of 14.7 times. The firm reiterated its Buy rating, highlighting the company's attractive growth prospects and potential for upside from strategic deals.

The analyst noted Addus HomeCare's clean balance sheet and robust cash flows as key factors supporting the positive outlook. These financial strengths are seen as providing a solid foundation for the company to continue its growth trajectory and pursue beneficial acquisitions in the future.

InvestingPro Insights

InvestingPro data reveals that Addus HomeCare Corporation (ADUS) is trading at a Price-to-Earnings (P/E) ratio of 25.11, which adjusts to a slightly lower 23.57 when considering the last twelve months as of Q4 2023. This places the company at an attractive valuation point, especially when paired with a PEG Ratio of 0.73 over the same period, suggesting that the stock may be undervalued relative to its earnings growth.

With a robust revenue growth of 11.31% in the last twelve months as of Q4 2023, and a solid operating income margin of 9.16%, Addus HomeCare's financials complement the positive sentiment from BofA Securities. The company's ability to generate strong cash flows, which can sufficiently cover interest payments, is an essential factor for investors considering the stability and sustainability of its earnings.

InvestingPro Tips highlight that analysts have revised their earnings upwards for the upcoming period and predict the company will be profitable this year, which aligns with BofA Securities' optimistic view. Moreover, the stock is trading near its 52-week high, reflecting investor confidence in the company's market position and growth potential. For those interested in deeper analysis, there are additional InvestingPro Tips available, providing further insight into Addus HomeCare's performance metrics and investment potential. Be sure to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.